- Home
- AVXL vs REAL Comparison
AVXL vs REAL Comparison
Compare AVXL & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVXL
- REAL
- Stock Information
- Founded
- AVXL 2004
- REAL 2011
- Country
- AVXL United States
- REAL United States
- Employees
- AVXL N/A
- REAL 3011
- Industry
- AVXL Biotechnology: Biological Products (No Diagnostic Substances)
- REAL Other Specialty Stores
- Sector
- AVXL Health Care
- REAL Consumer Discretionary
- Exchange
- AVXL Nasdaq
- REAL Nasdaq
- Market Cap
- AVXL 956.7M
- REAL 1.2B
- IPO Year
- AVXL N/A
- REAL 2019
- Fundamental
- Price
- AVXL $9.80
- REAL $10.35
- Analyst Decision
- AVXL Strong Buy
- REAL Strong Buy
- Analyst Count
- AVXL 2
- REAL 5
- Target Price
- AVXL $44.00
- REAL $11.70
- AVG Volume (30 Days)
- AVXL 1.2M
- REAL 4.1M
- Earning Date
- AVXL 08-12-2025
- REAL 11-03-2025
- Dividend Yield
- AVXL N/A
- REAL N/A
- EPS Growth
- AVXL N/A
- REAL N/A
- EPS
- AVXL N/A
- REAL N/A
- Revenue
- AVXL N/A
- REAL $636,971,000.00
- Revenue This Year
- AVXL N/A
- REAL $14.27
- Revenue Next Year
- AVXL N/A
- REAL $9.94
- P/E Ratio
- AVXL N/A
- REAL N/A
- Revenue Growth
- AVXL N/A
- REAL 12.68
- 52 Week Low
- AVXL $5.03
- REAL $2.71
- 52 Week High
- AVXL $14.44
- REAL $11.79
- Technical
- Relative Strength Index (RSI)
- AVXL 58.71
- REAL 58.58
- Support Level
- AVXL $8.80
- REAL $9.68
- Resistance Level
- AVXL $10.04
- REAL $11.79
- Average True Range (ATR)
- AVXL 0.49
- REAL 0.61
- MACD
- AVXL 0.18
- REAL -0.12
- Stochastic Oscillator
- AVXL 73.79
- REAL 34.20
About AVXL Anavex Life Sciences Corp.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.